ArticleBrain and behavior2025
A Causal Inference Study of Circulating Metabolites Mediating the Effect of Obesity-Related Indicators on the Incidence of Anxiety Disorders.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have reported an association between obesity and anxiety; however, these findings are inconclusive and subject to the risk of reverse causality.
methodsEmploying data from the UK Biobank and FinnGen Consortium, this study conducted genome-wide association studies (GWAS) and employed a two-sample Mendelian Randomization (MR) approach to investigate the association between genetic predictors of obesity and anxiety disorders (AD). A multivariable MR (MVMR) methodology quantified the proportion of the impact of obesity-related indicators on AD mediated by circulating metabolites, accompanied by sensitivity analyses to assess the robustness of the results.
resultsA univariate MR analysis demonstrated that a higher body fat percentage correlates with an elevated risk of anxiety (OR = 1.1428; p = 0.033). In contrast, increased levels of obesity and hyperalimentation were linked to a decreased risk of anxiety (OR = 0.9018; p = 0.044). Additionally, twelve circulating metabolites were identified as causally related to AD. Reverse causation MR analysis affirmed the lack of reverse causal influence of AD on obesity markers and circulating metabolites (p > 0.05). MVMR analysis revealed that body fat percentage and anxiety are interconnected through mediated pathways involving phenylalanine and the ratio of free cholesterol to total lipids in very small VLDL, with mediation effects recorded at 0.028 and 0.014, respectively. Furthermore, body fat percentage impacts anxiety via the ratio of linoleic acid to total fatty acids, demonstrating a partial mediation effect of -0.042, which accounts for 25% of the overall impact. Obesity and other hyperalimentations influence anxiety through phenylalanine, with a partial mediation effect of 0.006, accounting for 7.59% of the total effect.
conclusionThis study establishes a significant causal relationship between obesity and anxiety, with three circulating metabolites playing a clear mediating role. Thus, targeting these metabolites could significantly reduce the burden of AD associated with obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.